|
House Bill 2536 |
House Author: Oliverson et al. |
|
Effective: 9-1-19 |
Senate Sponsor: Hancock et al. |
House Bill 2536 amends the Health and Safety Code to require a pharmaceutical drug manufacturer to submit an annual report to the executive commissioner of the Health and Human Services Commission stating the current wholesale acquisition cost information for FDA‑approved drugs sold in or into Texas by that manufacturer. The bill also requires such a manufacturer to submit a report to the executive commissioner for certain drug price increases. The bill requires the executive commissioner to develop a website to provide the general public with the information in these reports.
House Bill 2536 amends the Insurance Code to require pharmacy benefit managers and health benefit plan issuers to submit annual reports containing certain information concerning prescription drug costs to the commissioner of insurance. The bill requires the commissioner to publish the aggregated data from these reports on the Texas Department of Insurance website.